New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
35th Annual Aerospace/Defense Conference is being held in New York on February 5-6 with webcasted company presentations to begin on February 5 at 9 am. Webcast Link
News For A;CVU;EGL;ANTH;CRS;KEYW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 31, 2015
16:36 EDTCRSCarpenter Technology sees Q3 EPS (9c)-(5c), consensus 57c
Subscribe for More Information
16:33 EDTCRSCarpenter Technology announces workforce reduction of approximately 10%
Subscribe for More Information
March 30, 2015
18:01 EDTARigaku Corp. to acquire Agilent's X-ray diffraction business
Subscribe for More Information
06:03 EDTANTHAnthera price target raised to $7.50 from $5 at Piper Jaffray
Piper Jaffray raised its price target for shares of Anthera Pharmaceuticals to $7.50 saying the company's strengthened balance sheet is enough to fund its Phase III trials. It reiterates an Overweight rating on the stock.
March 25, 2015
09:11 EDTEGLEngility Holdings called a 'diamond in the rough' at FBR Capital
FBR Capital says one-time adjustments in 2015 give investors an opportunity to own "diamond in the rough" Engility Holdings. FBR expects Engility to benefit from close to zero taxes for at least the next half-decade and generate solid free cash flow. It thinks 2016 earnings should start to normalize and show the company's underlying earnings growth story. FBR keeps an Outperform rating on Engility with a $45 price target.
March 24, 2015
12:45 EDTEGLEngility Holdings price target lowered to $46 from $56 at Maxim
Maxim lowered its price target for Engility Holdings to $46 citing continued pressure in the company's Department of Defense business. The firm believes Engility's pipeline "remains solid" and it keeps a Buy rating on the name.
09:10 EDTADako announces collaboration agreement with Amgen
Dako, an Agilent Technologies (A) company, announced a new Master Collaboration Agreement with Amgen (AMGN). The expanded collaboration will allow both companies to benefit from knowledge-sharing within the field of drug-diagnostic research and development in general, and in relation to companion diagnostic products in particular. The financial details of the agreement were not disclosed.
08:46 EDTCVUCPI Aerostructures awarded $1.21M contract by Northrop Grumman
Subscribe for More Information
07:32 EDTEGLEngility Holdings awarded $34.9M contract
Subscribe for More Information
06:04 EDTEGLEngility Holdings sees FY15 adjusted EPS $1.70-$2.20, consensus $1.71
Sees FY15 revenue $2B-$2.3B, consensus $2.21B.
March 23, 2015
16:13 EDTEGLEngility Holdings awarded IDIQ contract from USAID with $1B ceiling
Engility Holdings announced it has been awarded an Indefinite Delivery Indefinite Quantity, IDIQ, multiple-award contract with a $1B ceiling to provide technical advisory services to the U.S. Agency for International Development, USAID. The five-year contract represents a continuation of Engility's work under the previous Water II IDIQ Contract. Task orders issued under this new award can be cost plus fixed fee or firm fixed price.Under the requirements of the Water and Development IDIQ, WADI, Engility will provide a range of technical services, including multi-year projects, to USAID/Washington bureaus and USAID missions worldwide. The focus of this work will be to promote food security and advance development through improvements to water, supply, sanitation and hygiene, and the sound management of water.
10:09 EDTEGLEngility Holdings management to meet with CRT Capital
Meeting to be held in New York on March 25 hosted by CRT Capital.
10:08 EDTEGLEngility Holdings management to meet with FBR Capital
Subscribe for More Information
March 20, 2015
09:14 EDTEGLEngility Holdings to host conference call
Subscribe for More Information
March 19, 2015
15:02 EDTANTHAnthera gets $3M research award from Cystic Fibrosis Foundation
Anthera Pharmaceuticals announced it has received an award from Cystic Fibrosis Foundation Therapeutic of up to $3M to support the manufacturing and clinical development of Anthera's novel pancreatic enzyme replacement therapy, Sollpura-liprotamase. Cystic Fibrosis Foundation Therapeutics is a non-profit affiliate of the Cystic Fibrosis Foundation.
10:31 EDTKEYWKEYW awarded $38M contract to provide cyber training, infrastructure upgrades
Subscribe for More Information
March 18, 2015
10:31 EDTKEYWKEYW acquires Ponte Technologies and Milestone Intelligence Group
KEYW announced it has acquired Ponte Technologies and Milestone Intelligence Group, increasing its cyber capabilities for both government and commercial customers. As a result of these acquisitions, KEYW has formed a new sector called Emerging Technologies and Markets to focus on opportunities
09:23 EDTANTHOn The Fly: Pre-market Movers
Subscribe for More Information
08:45 EDTANTHAnthera Pharmaceuticals 5.5M share Spot Secondary priced at $4.50
Subscribe for More Information
08:31 EDTAAgilent names president and COO Mike McMullen as CEO
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use